BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cosio FG, Cattran DC. Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation. Kidney Int. 2017;91:304-314. [PMID: 27837947 DOI: 10.1016/j.kint.2016.08.030] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Wu Q, Liang D, Song T, Ni X, Wu X, Zhang M, Chen J, Cheng D, Xie K, Li X, Wen J. Poor outcomes of proliferative glomerulonephritis with monoclonal IgG deposits in renal allografts: a retrospective multicenter study. J Nephrol 2022. [PMID: 35867238 DOI: 10.1007/s40620-022-01385-y] [Reference Citation Analysis]
2 Miura K, Kaneko N, Hashimoto T, Ishizuka K, Shirai Y, Hisano M, Chikamoto H, Akioka Y, Kanda S, Harita Y, Yamamoto T, Hattori M. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome. Pediatr Nephrol 2022. [PMID: 35655039 DOI: 10.1007/s00467-022-05604-3] [Reference Citation Analysis]
3 Smarz-Widelska I, Chojęta D, Kozioł MM. The Role of Anti-PLA2R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice. Int J Environ Res Public Health 2022;19:5301. [PMID: 35564696 DOI: 10.3390/ijerph19095301] [Reference Citation Analysis]
4 Caliskan Y, Lee B, Whelan AM, Abualrub F, Lentine KL, Jittirat A. Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment. Curr Transpl Rep. [DOI: 10.1007/s40472-021-00340-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zanoni F, Khairallah P, Kiryluk K, Batal I. Glomerular Diseases of the Kidney Allograft: Toward a Precision Medicine Approach. Seminars in Nephrology 2022;42:29-43. [DOI: 10.1016/j.semnephrol.2022.01.005] [Reference Citation Analysis]
6 Uffing A, Hullekes F, Riella LV, Hogan JJ. Recurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas. Clin J Am Soc Nephrol 2021;16:1730-42. [PMID: 34686531 DOI: 10.2215/CJN.00280121] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Miura K, Ando T, Kanda S, Hashimoto T, Kaneko N, Ishizuka K, Hamada R, Hataya H, Hotta K, Gotoh Y, Nishiyama K, Hamasaki Y, Shishido S, Fujita N, Hattori M. Response to steroid and immunosuppressive therapies may predict post-transplant recurrence of steroid-resistant nephrotic syndrome. Pediatr Transplant 2021;:e14103. [PMID: 34309142 DOI: 10.1111/petr.14103] [Reference Citation Analysis]
8 Codina S, Manonelles A, Tormo M, Sola A, Cruzado JM. Chronic Kidney Allograft Disease: New Concepts and Opportunities. Front Med (Lausanne) 2021;8:660334. [PMID: 34336878 DOI: 10.3389/fmed.2021.660334] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Maniar A, Hooper DK, Sethna CB, Singer P, Traum A, Benoit E, Kotzen E, Verghese P, Garro R, Kamel M, Ranch D, Shih W, Jain NG, Al-Akash S. Re-transplantation in pediatric patients with failure of primary transplant due to recurrent focal segmental glomerulosclerosis: A pediatric nephrology research consortium study. Pediatr Transplant 2021;:e14085. [PMID: 34247442 DOI: 10.1111/petr.14085] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Heybeli C, Alexander MP, Bentall AJ, Amer H, Buadi FK, Dean PG, Dingli D, Dispenzieri A, El Ters M, Gertz MA, Issa NS, Kapoor P, Kourelis T, Kukla A, Kumar S, Lacy MQ, Lorenz EC, Muchtar E, Murray DL, Nasr SH, Prieto M, Rajkumar SV, Schinstock CA, Stegall MD, Warsame R, Leung N. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series. Am J Kidney Dis 2021:S0272-6386(21)00692-2. [PMID: 34175375 DOI: 10.1053/j.ajkd.2021.04.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ishizuka K, Miura K, Hashimoto T, Kaneko N, Harita Y, Yabuuchi T, Hisano M, Fujinaga S, Omori T, Yamaguchi Y, Hattori M. Degree of foot process effacement in patients with genetic focal segmental glomerulosclerosis: a single-center analysis and review of the literature. Sci Rep 2021;11:12008. [PMID: 34103591 DOI: 10.1038/s41598-021-91520-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 De Souza L, Prunster J, Chan D, Chakera A, Lim WH. Recurrent glomerulonephritis after kidney transplantation: a practical approach. Curr Opin Organ Transplant 2021;26:360-80. [PMID: 34039882 DOI: 10.1097/MOT.0000000000000887] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Kielar M, Gala-Błądzińska A, Dumnicka P, Ceranowicz P, Kapusta M, Naumnik B, Kubiak G, Kuźniewski M, Kuśnierz-Cabala B. Complement Components in the Diagnosis and Treatment after Kidney Transplantation-Is There a Missing Link? Biomolecules 2021;11:773. [PMID: 34064132 DOI: 10.3390/biom11060773] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Park WY, Kim Y, Paek JH, Jin K, Han S. Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients. Kidney Res Clin Pract 2021;40:317-24. [PMID: 33866766 DOI: 10.23876/j.krcp.20.183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Tesar V, Hruskova Z. Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy. Front Immunol 2021;12:593288. [PMID: 33828546 DOI: 10.3389/fimmu.2021.593288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Puttarajappa CM, Schinstock CA, Wu CM, Leca N, Kumar V, Vasudev BS, Hariharan S. KDOQI US Commentary on the 2020 KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Am J Kidney Dis 2021;77:833-56. [PMID: 33745779 DOI: 10.1053/j.ajkd.2020.11.017] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Berchtold L, Letouzé E, Alexander MP, Canaud G, Logt AVD, Hamilton P, Mousson C, Vuiblet V, Moyer AM, Guibert S, Mrázová P, Levi C, Dubois V, Cruzado JM, Torres A, Gandhi MJ, Yousfi N, Tesar V, Viklický O, Hourmant M, Moulin B, Rieu P, Choukroun G, Legendre C, Wetzels J, Brenchley P, Ballarín Castan JA, Debiec H, Ronco P. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney International 2021;99:671-85. [DOI: 10.1016/j.kint.2020.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
18 Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, Kumar D, Oberbauer R, Pascual J, Pilmore HL, Rodrigue JR, Segev DL, Sheerin NS, Tinckam KJ, Wong G, Knoll GA. KDIGO Clinical Practice Guideline on the evaluation and management of candidates for kidney transplantation. Transplantation. 2020;104:S11-S103. [PMID: 32301874 DOI: 10.1097/tp.0000000000003136] [Cited by in Crossref: 60] [Cited by in F6Publishing: 110] [Article Influence: 60.0] [Reference Citation Analysis]
19 Ban H, Miura K, Kaneko N, Shirai Y, Yabuuchi T, Ishizuka K, Chikamoto H, Akioka Y, Shimizu S, Ishida H, Tanabe K, Hattori M. Amount and selectivity of proteinuria may predict the treatment response in post-transplant recurrence of focal segmental glomerulosclerosis: a single-center retrospective study. Pediatr Nephrol 2021;36:2433-42. [PMID: 33538912 DOI: 10.1007/s00467-021-04951-x] [Reference Citation Analysis]
20 Alcalde-bezhold G, Alcázar-arroyo R, Angoso-de-guzmán M, Arenas MD, Arias-guillén M, Arribas-cobo P, Díaz-gómez JM, García-maset R, González-parra E, Hernández-marrero D, Herrero-calvo JA, Maduell F, Molina P, Molina-núñez M, Otero-gonzález A, Pascual J, Pereira-garcía M, Pérez-garcía R, Dolores del Pino y Pino M, Prieto-velasco M, Pulido JFP, Sánchez-álvarez JE, Sánchez-hernández R, de Sequera-ortiz P. Hemodialysis Centers Guide 2020. Nefrología (English Edition) 2021;41:1-77. [DOI: 10.1016/s2013-2514(22)00042-6] [Reference Citation Analysis]
21 Aiyegbusi O, McGregor L, McGeoch L, Kipgen D, Geddes CC, Stevens KI. Renal Disease in Primary Sjögren's Syndrome. Rheumatol Ther 2021;8:63-80. [PMID: 33367966 DOI: 10.1007/s40744-020-00264-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
22 Bobart SA, Alexander MP, Bentall A. Recurrent Glomerulonephritis in the Kidney Allograft. Indian J Nephrol 2020;30:359-69. [PMID: 33840954 DOI: 10.4103/ijn.IJN_193_19] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Chen CC, Lin WC, Lee CY, Yang CY, Tsai MK. Two-year protocol biopsy after kidney transplantation in clinically stable recipients - a retrospective study. Transpl Int 2021;34:185-93. [PMID: 33152140 DOI: 10.1111/tri.13785] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Gonzalez Suarez ML, Thongprayoon C, Hansrivijit P, Kovvuru K, Kanduri SR, Aeddula NR, Pivovarova AI, Chewcharat A, Bathini T, Mao MA, Basu A, Cheungpasitporn W. Treatment of C3 Glomerulopathy in Adult Kidney Transplant Recipients: A Systematic Review. Med Sci (Basel) 2020;8:E44. [PMID: 33096866 DOI: 10.3390/medsci8040044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Aziz F, Garg N, Singh T, Djamali A, Mandelbrot D. Kidney transplantation for primary glomerulonephritis: Recurrence risk and graft outcomes with related versus unrelated donors. Transplant Rev (Orlando) 2021;35:100584. [PMID: 33069562 DOI: 10.1016/j.trre.2020.100584] [Reference Citation Analysis]
26 Chukwu CA, Middleton R, Kalra PA. Recurrent glomerulonephritis after renal transplantation. Current Opinion in Nephrology & Hypertension 2020;29:636-44. [DOI: 10.1097/mnh.0000000000000643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Kawabe M, Yamamoto I, Yamakawa T, Katsumata H, Isaka N, Katsuma A, Nakada Y, Kobayashi A, Koike K, Ueda H, Tanno Y, Koike Y, Miki J, Yamada H, Kimura T, Ohkido I, Tsuboi N, Yamamoto H, Kojima H, Yokoo T. Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation. Front Immunol 2020;11:2068. [PMID: 33013875 DOI: 10.3389/fimmu.2020.02068] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Infante B, Rossini M, Leo S, Troise D, Netti GS, Ranieri E, Gesualdo L, Castellano G, Stallone G. Recurrent Glomerulonephritis after Renal Transplantation: The Clinical Problem. Int J Mol Sci 2020;21:E5954. [PMID: 32824988 DOI: 10.3390/ijms21175954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Jacobs-Cachá C, Vergara A, García-Carro C, Agraz I, Toapanta-Gaibor N, Ariceta G, Moreso F, Serón D, López-Hellín J, Soler MJ. Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers. Clin Kidney J 2021;14:482-91. [PMID: 33623672 DOI: 10.1093/ckj/sfaa110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Infante B, Rossini M, Di Lorenzo A, Coviello N, Giuseppe C, Gesualdo L, Giuseppe G, Stallone G. Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy. Clin Kidney J 2020;13:758-67. [PMID: 33123355 DOI: 10.1093/ckj/sfaa060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
31 Buxeda A, Said SM, Nasr SH, Leung N, El Ters M, Cosio FG. Recurrent Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allografts Treated With Anti-CD20 Antibodies. Transplantation 2019;103:1477-85. [PMID: 30747850 DOI: 10.1097/TP.0000000000002577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
32 Batal I, Vasilescu ER, Dadhania DM, Adel AA, Husain SA, Avasare R, Serban G, Santoriello D, Khairallah P, Patel A, Moritz MJ, Latulippe E, Riopel J, Khallout K, Swanson SJ, Bomback AS, Mohan S, Ratner L, Radhakrishnan J, Cohen DJ, Appel GB, Stokes MB, Markowitz GS, Seshan SV, De Serres SA, Andeen N, Loupy A, Kiryluk K, D'Agati VD. Association of HLA Typing and Alloimmunity With Posttransplantation Membranous Nephropathy: A Multicenter Case Series. Am J Kidney Dis 2020;76:374-83. [PMID: 32359820 DOI: 10.1053/j.ajkd.2020.01.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
33 Figueiredo Júnior HE, Nascimento E, Lasmar MF, Siqueira RG, Sousa RN, Fabreti-Oliveira RA. Effect of Glomerulopathy Recurrence in the Outcome and Graft Survival of Kidney Transplanted Patients. Transplant Proc 2020;52:1272-8. [PMID: 32245622 DOI: 10.1016/j.transproceed.2020.02.030] [Reference Citation Analysis]
34 Yuzefovych Y, Valdivia E, Rong S, Hack F, Rother T, Schmitz J, Bräsen JH, Wedekind D, Moers C, Wenzel N, Gueler F, Blasczyk R, Figueiredo C. Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During ex vivo Organ Perfusion. Front Immunol 2020;11:265. [PMID: 32140158 DOI: 10.3389/fimmu.2020.00265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
35 Sharma A, Hariharan S. Octreotide Delaying the Progression of Recurrent IgA Nephropathy After Kidney Transplantation. Transplant Direct 2020;6:e518. [PMID: 32047846 DOI: 10.1097/TXD.0000000000000963] [Reference Citation Analysis]
36 Van Loon E, Bernards J, Van Craenenbroeck AH, Naesens M. The Causes of Kidney Allograft Failure: More Than Alloimmunity. A Viewpoint Article. Transplantation 2020;104:e46-56. [DOI: 10.1097/tp.0000000000003012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
37 Jacobs-Cachá C, Puig-Gay N, Helm D, Rettel M, Sellarès J, Meseguer A, Savitski MM, Moreso FJ, Soler MJ, Seron D, Lopez-Hellin J. A misprocessed form of Apolipoprotein A-I is specifically associated with recurrent Focal Segmental Glomerulosclerosis. Sci Rep 2020;10:1159. [PMID: 31980684 DOI: 10.1038/s41598-020-58197-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
38 English M, Hawryluk E, Krupnick R, Kumar MSA, Schwartz J. The Symptoms and Impact of Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Conceptual Model of the Patient Experience. Adv Ther 2019;36:3390-408. [PMID: 31612357 DOI: 10.1007/s12325-019-01110-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Grafals M, Sharfuddin A. Adrenocorticotropic Hormone in the Treatment of Focal Segmental Glomerulosclerosis Following Kidney Transplantation. Transplant Proc 2019;51:1831-7. [PMID: 31399168 DOI: 10.1016/j.transproceed.2019.04.052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
40 Cravedi P, Jarque M, Angeletti A, Favà À, Cantarelli C, Bestard O. Immune-Monitoring Disease Activity in Primary Membranous Nephropathy. Front Med (Lausanne) 2019;6:241. [PMID: 31788474 DOI: 10.3389/fmed.2019.00241] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
41 Singh T, Astor BC, Zhong W, Mandelbrot DA, Maursetter L, Panzer SE. The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation. Clin Transplant 2019;33:e13738. [PMID: 31630440 DOI: 10.1111/ctr.13738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
42 Lim WH, Shingde M, Wong G. Recurrent and de novo Glomerulonephritis After Kidney Transplantation. Front Immunol 2019;10:1944. [PMID: 31475005 DOI: 10.3389/fimmu.2019.01944] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
43 Lu T, Zhao W, Zhang F, Qi X, Yang Y, Gu C. Lycium barbarum polysaccharides attenuate rat anti-Thy-1 glomerulonephritis through mediating pyruvate dehydrogenase. Biomedicine & Pharmacotherapy 2019;116:109020. [DOI: 10.1016/j.biopha.2019.109020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Passerini P, Malvica S, Tripodi F, Cerutti R, Messa P. Membranous Nephropathy (MN) Recurrence After Renal Transplantation. Front Immunol 2019;10:1326. [PMID: 31244861 DOI: 10.3389/fimmu.2019.01326] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
45 Alhamad T, Manllo Dieck J, Younus U, Matar D, Alasfar S, Vujjini V, Wall D, Kanawati B, Reiser J, Brennan DC, Alachkar N. ACTH Gel in Resistant Focal Segmental Glomerulosclerosis After Kidney Transplantation. Transplantation 2019;103:202-9. [PMID: 29894413 DOI: 10.1097/TP.0000000000002320] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
46 Park S, Go H, Baek CH, Kim YH, Kim YC, Yang SH, Lee JP, Min SI, Ha J, Song EY, Kim YS, Park SK, Lee H, Moon KC. Clinical importance of the updated Oxford classification in allograft IgA nephropathy. Am J Transplant 2019;19:2855-64. [PMID: 31017369 DOI: 10.1111/ajt.15400] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
47 Anigilaje EA, Olutola A. Prospects of genetic testing for steroid-resistant nephrotic syndrome in Nigerian children: a narrative review of challenges and opportunities. Int J Nephrol Renovasc Dis 2019;12:119-36. [PMID: 31190951 DOI: 10.2147/IJNRD.S193874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Martín‐penagos L, Benito‐hernández A, San Segundo D, Sango C, Azueta A, Gómez‐román J, Fernández‐fresnedo G, López‐hoyos M, Ruiz JC, Rodrigo E. A proliferation‐inducing ligand increase precedes IgA nephropathy recurrence in kidney transplant recipients. Clin Transplant 2019;33:e13502. [DOI: 10.1111/ctr.13502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
49 Jo HA, Han SS, Lee S, Kim JY, Yang SH, Lee H, Yang JS, Lee JP, Joo KW, Lim CS, Kim YS, Ahn C, Han JS, Kim DK. The association of tumor necrosis factor superfamily 13 with recurrence of immunoglobulin A nephropathy in living related kidney transplantation. BMC Nephrol 2019;20:33. [PMID: 30704417 DOI: 10.1186/s12882-019-1222-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Srivastava P, Solanki AK, Arif E, Wolf BJ, Janech MG, Budisavljevic MN, Kwon SH, Nihalani D. Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients. Kidney Int 2019;95:708-16. [PMID: 30709661 DOI: 10.1016/j.kint.2018.10.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
51 Regunathan-Shenk R, Avasare RS, Ahn W, Canetta PA, Cohen DJ, Appel GB, Bomback AS. Kidney Transplantation in C3 Glomerulopathy: A Case Series. Am J Kidney Dis 2019;73:316-23. [PMID: 30413277 DOI: 10.1053/j.ajkd.2018.09.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
52 da Silva AQB, de Sandes-Freitas TV, Mansur JB, Medicina-Pestana JO, Mastroianni-Kirsztajn G. Clinical Presentation, Outcomes, and Treatment of Membranous Nephropathy after Transplantation. Int J Nephrol 2018;2018:3720591. [PMID: 30112208 DOI: 10.1155/2018/3720591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Siemens TA, Riella MC, Moraes TP, Riella CV. APOL1 risk variants and kidney disease: what we know so far. J Bras Nefrol 2018;40:388-402. [PMID: 30052698 DOI: 10.1590/2175-8239-JBN-2017-0033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
54 Murakami N, Ding Y, Cohen DJ, Chandraker AK, Rennke HG. Recurrent membranous nephropathy and acute cellular rejection in a patient treated with direct anti-HCV therapy (ledipasvir/sofosbuvir). Transpl Infect Dis 2018;20:e12959. [PMID: 29968947 DOI: 10.1111/tid.12959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Yamamoto I, Yamakawa T, Katsuma A, Kawabe M, Katsumata H, Hamada AM, Nakada Y, Kobayashi A, Yamamoto H, Yokoo T. Recurrence of native kidney disease after kidney transplantation: Recurrence of native GN after KTx. Nephrology 2018;23:27-30. [DOI: 10.1111/nep.13284] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
56 Kim SM, Song IH. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management. Korean J Intern Med 2018;33:670-8. [PMID: 29961309 DOI: 10.3904/kjim.2018.202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
57 Park S, Baek CH, Cho H, Yu M, Kim YC, Go H, Kim YH, Lee JP, Min SI, Ha J, Moon KC, Kim YS, Ahn C, Park S, Lee H. Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy. Am J Transplant 2018;19:145-55. [DOI: 10.1111/ajt.14908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
58 Steyaert S, Van Dorpe J, Hoorens A, Van Biesen W, Van Laecke S. Intravenous immunoglobulins modify relapsing membranous glomerulonephritis after kidney transplantation: a case report. Acta Clin Belg 2018;73:229-32. [PMID: 28805142 DOI: 10.1080/17843286.2017.1361622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
59 Zagkotsis G, Vourlakou C, Paraskevopoulos A, Apostolou T. Recurrence of crescentic IgA nephropathy after renal transplantation. CEN Case Rep 2018;7:268-73. [PMID: 29802527 DOI: 10.1007/s13730-018-0341-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
60 Blosser CD, Bloom RD. Recurrent glomerular disease after kidney transplantation. Curr Opin Nephrol Hypertens 2017;26:501-8. [PMID: 28832357 DOI: 10.1097/MNH.0000000000000358] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
61 Said SM, Cosio FG, Valeri AM, Leung N, Sethi S, Salameh H, Cornell LD, Fidler ME, Alexander MP, Fervenza FC, Drosou ME, Zhang D, D'Agati VD, Nasr SH. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft. Kidney Int 2018;94:159-69. [PMID: 29716794 DOI: 10.1016/j.kint.2018.01.028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
62 Martin-moreno P, Rifon J, Errasti P. Efficacy of the Combination of Immunoadsorption and Rituximab for Treatment in a Case of Severe Focal and Segmental Glomerulosclerosis Recurrence after Renal Transplantation. Blood Purif 2018;46:90-3. [DOI: 10.1159/000488638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
63 Vazquez Martul E. [The pathology of renal transplants]. Rev Esp Patol 2018;51:110-23. [PMID: 29602372 DOI: 10.1016/j.patol.2017.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Deng R, Dai Y, Zhang H, Liu L, Li J, Xiong Y, Deng S, Fu Q, Wang C. Higher Incidence of Renal Allograft Glomerulonephritis in Living-Related Donor Kidney Transplantation. Transplant Proc 2018;50:2421-5. [PMID: 30316370 DOI: 10.1016/j.transproceed.2018.03.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Cordeiro Cabral DB, de Sandes-Freitas TV, Medina-Pestana JO, Mastroianni-Kirsztajn G. Clinical Features, Treatment and Prognostic Factors of Post-Transplant Immunoglobulin A Nephropathy. Ann Transplant 2018;23:166-75. [PMID: 29519995 [PMID: 29519995 DOI: 10.12659/aot.907167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
66 Lepori N, Zand L, Sethi S, Fernandez-Juarez G, Fervenza FC. Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults. Clin Kidney J 2018;11:179-90. [PMID: 29644057 DOI: 10.1093/ckj/sfx143] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
67 Abbas F, El Kossi M, Jin JK, Sharma A, Halawa A. Recurrence of primary glomerulonephritis: Review of the current evidence. World J Transplant 2017; 7(6): 301-316 [PMID: 29312859 DOI: 10.5500/wjt.v7.i6.301] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
68 Singh T, Astor B, Zhong W, Mandelbrot D, Djamali A, Panzer S. Kidney Transplant Recipients With Primary Membranous Glomerulonephritis Have a Higher Risk of Acute Rejection Compared With Other Primary Glomerulonephritides. Transplant Direct 2017;3:e223. [PMID: 29184911 DOI: 10.1097/TXD.0000000000000736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
69 Xipell M, Rodas LM, Villarreal J, Molina A, Reinoso-Moreno J, Blasco M, Poch E, Diekmann F, Campistol JM, Quintana LF. The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation. Clin Kidney J 2018;11:422-8. [PMID: 29988247 DOI: 10.1093/ckj/sfx128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
70 Lloyd IE, Ahmed F, Revelo MP, Khalighi MA. De novo immune complex deposition in kidney allografts: a series of 32 patients. Hum Pathol 2018;71:109-16. [PMID: 29079181 DOI: 10.1016/j.humpath.2017.10.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
71 Van Loon E, Lerut E, Naesens M. The time dependency of renal allograft histology. Transpl Int 2017;30:1081-91. [DOI: 10.1111/tri.13042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
72 de Fijter JW. Recurrence of glomerulonephritis: an underestimated and unmet medical need. Kidney Int 2017;92:294-6. [PMID: 28709599 DOI: 10.1016/j.kint.2017.04.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
73 Couser WG. Primary Membranous Nephropathy. Clin J Am Soc Nephrol 2017;12:983-97. [PMID: 28550082 DOI: 10.2215/CJN.11761116] [Cited by in Crossref: 175] [Cited by in F6Publishing: 212] [Article Influence: 35.0] [Reference Citation Analysis]